- Home
- QTRX
as 04-18-2025 1:42pm EST
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 201.7M | IPO Year: | 2017 |
| Target Price: | $18.25 | AVG Volume (30 days): | 764.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.67 - $19.18 | Next Earning Date: | 05-06-2025 |
| Revenue: | $137,421,000 | Revenue Growth: | 12.30% |
| Revenue Growth (this year): | 5.22% | Revenue Growth (next year): | 15.31% |
Latest Quanterix Corporation News
QTRX Breaking Stock News: Dive into QTRX Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
Business Wire
12 days ago
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya
Business Wire
18 days ago
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
PR Newswire
a month ago
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
Simply Wall St.
a month ago
Quanterix Full Year 2024 Earnings: EPS Misses Expectations
Thomson Reuters StreetEvents
a month ago
Q4 2024 Quanterix Corp Earnings Call
GuruFocus.com
a month ago
Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
MT Newswires
a month ago
Quanterix Q4 Net Loss Widens, Revenue Rises, 2025 Revenue Outlook Set
Compare QTRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QTRX Quanterix Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.